In the dynamic landscape of pharmaceutical contract manufacturing, the relationship between pharmaceutical companies and CMOs has evolved significantly. Traditionally, a hierarchical power dynamic often prevailed, with pharmaceutical companies dictating terms and CMOs playing a more subservient role. However, recent trends have highlighted the need for a paradigm shift towards a more collaborative and equitable partnership. This session will explore the factors driving this power shift
Check out the incredible speaker line-up to see who will be joining Marta.
Download The Latest Agenda